enGene Reports First Quarter 2024 Financial Results & Recent Corporate Progress
enGene To Present at the Leerink Partners Global Biopharma Conference
Gene therapy startup enGene became a public biotech on Wednesday after completing its combination with Forbion European Acquisition, a blank check company formed in 2021.